These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7620108)

  • 1. Study on the comparative immunogenicity of a recombinant DNA hepatitis B vaccine containing pre-S components of the HBV coat protein with non pre-S containing vaccines.
    Yap I; Guan R; Chan SH
    J Gastroenterol Hepatol; 1995; 10(1):51-5. PubMed ID: 7620108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant DNA hepatitis B vaccine containing Pre-S components of the HBV coat protein--a preliminary study on immunogenicity.
    Yap I; Guan R; Chan SH
    Vaccine; 1992; 10(7):439-42. PubMed ID: 1535170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of a new mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in adults.
    Raz R; Koren R; Bass D
    Isr Med Assoc J; 2001 May; 3(5):328-32. PubMed ID: 11411195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in neonates.
    Yerushalmi B; Raz R; Blondheim O; Shumov E; Koren R; Dagan R
    Pediatr Infect Dis J; 1997 Jun; 16(6):587-92. PubMed ID: 9194109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines.
    Shouval D; Ilan Y; Adler R; Deepen R; Panet A; Even-Chen Z; Gorecki M; Gerlich WH
    Vaccine; 1994 Nov; 12(15):1453-9. PubMed ID: 7533967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in children.
    Raz R; Dagan R; Gallil A; Brill G; Kassis I; Koren R
    Vaccine; 1996 Feb; 14(3):207-11. PubMed ID: 8920701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the immunogenicity of a recombinant vaccine against hepatitis B containing S and pre-S2 sequences using two different schedules.
    Gizaris V; Roumeliotou A; Ktenas E; Papoutsakis G; Papaevangelou G
    Vaccine; 1993 Nov; 11(14):1445-7. PubMed ID: 8310765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactogenicity and immunogenicity of a new recombinant hepatitis B vaccine containing Pre S antigens: a preliminary report.
    Hourvitz A; Mosseri R; Solomon A; Yehezkelli Y; Atsmon J; Danon YL; Koren R; Shouval D
    J Viral Hepat; 1996 Jan; 3(1):37-42. PubMed ID: 8736239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B Virus Revaccination With Standard Versus Pre-S Vaccine in Previously Immunized Patients With Celiac Disease.
    Heshin-Bekenstein M; Turner D; Shamir R; Bar-Meir M; Dagan R; Zevit N; Silbermintz A
    J Pediatr Gastroenterol Nutr; 2015 Oct; 61(4):400-3. PubMed ID: 25988560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B vaccination in diabetic patients. Randomized trial comparing recombinant vaccines containing and not containing pre-S2 antigen.
    Douvin C; Simon D; Charles MA; Deforges L; Bierling P; Lehner V; Budkowska A; Dhumeaux D
    Diabetes Care; 1997 Feb; 20(2):148-51. PubMed ID: 9118762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.
    Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH
    Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of a 'pre-S2 plus S' hepatitis B vaccine in healthy adults.
    Katkov WN; Watkins E; DeMelia HC; Dienstag JL
    J Viral Hepat; 1994; 1(1):79-83. PubMed ID: 8790563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new pre-S containing recombinant hepatitis B vaccine and its effect on non-responders: a preliminary observation.
    Yap I; Chan SH
    Ann Acad Med Singap; 1996 Jan; 25(1):120-2. PubMed ID: 8779530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of two recombinant hepatitis B vaccines in older individuals.
    Treadwell TL; Keeffe EB; Lake J; Read A; Friedman LS; Goldman IS; Howell CD; DeMedina M; Schiff ER; Jensen DM
    Am J Med; 1993 Dec; 95(6):584-8. PubMed ID: 8259774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, controlled clinical trial to evaluate the immunogenicity of a PreS/S hepatitis B vaccine Sci-B-Vac™, as compared to Engerix B
    Elhanan E; Boaz M; Schwartz I; Schwartz D; Chernin G; Soetendorp H; Gal Oz A; Agbaria A; Weinstein T
    Clin Exp Nephrol; 2018 Feb; 22(1):151-158. PubMed ID: 28456864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on the immuno-effects and influencing factors of Chinese hamster ovary (CHO) cell hepatitis B vaccine among adults, under different dosages].
    Zhang W; Lin CY; Han LL; Li LQ; Gao P; Lin H; Gong XH; Huang F; Tang YQ; Ma JX; Zhang HY; Wang C; Yang P; Li H; Sun MP; He X; Pang XH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Jul; 31(7):767-70. PubMed ID: 21162840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S vaccine.
    Shouval D; Roggendorf H; Roggendorf M
    Med Microbiol Immunol; 2015 Feb; 204(1):57-68. PubMed ID: 25557605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of three recombinant hepatitis B vaccines administered to students in three doses containing half the antigen amount routinely used for adult vaccination.
    Baldy JL; de Lima GZ; Morimoto HK; Reiche EM; Matsuo T; de Mattos ED; Sudan LC
    Rev Inst Med Trop Sao Paulo; 2004; 46(2):103-7. PubMed ID: 15141282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid seroprotection against hepatitis B following the first dose of a Pre-S1/Pre-S2/S vaccine.
    Shapira MY; Zeira E; Adler R; Shouval D
    J Hepatol; 2001 Jan; 34(1):123-7. PubMed ID: 11211888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative safety and immunogenicity of yeast recombinant hepatitis B vaccines containing S and pre-S2 + S antigens.
    Miskovsky E; Gershman K; Clements ML; Cupps T; Calandra G; Hesley T; Ioli V; Ellis R; Kniskern P; Miller W
    Vaccine; 1991 May; 9(5):346-50. PubMed ID: 1872019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.